Comorbidities in methylphenidate users compared to nonusers in Germany

Astrid Angela Kraut, Ingo Langner, Rafael Mikolajczyk, Christina Lindemann & Edeltraut Garbe
Background: Methylphenidate is mainly prescribed in children and adolescents with attention deficit / hyperactivity disorder (ADHD). The use of methylphenidate is contraindicated in the presence of certain psychiatric, cerebro- and cardiovascular conditions. In this study, we estimated the frequency[for full text, please go to the a.m. URL]